NSE · BIOFILCHEM
Biofil Chemicals & Pharmaceuticals Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,410
of 5,072 stocks
▼ 141W
Peak #3,396 · 21 Sep 2026
Operating in Chemicals, Biofil Chemicals & Pharmaceuticals Limited is seeing revenue contract sharply, trades at a moderate earnings multiple, and earns a healthy return on equity.
Market Cap
52.79 Cr
P/E Ratio
18.97
P/B Ratio
2.45
ROE
12.92%
ROCE
15.61%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 12.35 Cr | 7.57 Cr | 85.63 L | 13.54 Cr |
| Net Profit | 10.91 L | 21.22 L | 7.92 L | 8.36 L |
| EPS | 0.07 | 0.13 | 0.05 | 0.05 |
| Operating Profit | 13.48 L | 46.90 L | 10.72 L | 11.18 L |
Shareholding pattern
Promoter
46.79%
Public
53.21%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 23 Sep 2024 | Other | Annual General Meeting |
| 20 Sep 2023 | Other | Annual General Meeting |
| 21 Sep 2022 | Other | Annual General Meeting |
| 17 Sep 2021 | Other | Annual General Meeting |
| 21 Sep 2020 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.